“What attracted us to Dacia Plant is the trust that Romanians place in this brand and we know from experience that such trust is earned only through excellent products that do not compromise.” said Mario Debel, CEO of Ceres Pharma.
CERES Pharma wants to expand its portfolio of natural products and says it wants to turn Dacia Plant into the most important exporter of natural products in Romania and a major player on the European market of natural food supplements.
“We are happy that Dacia Plant is entering a new stage of development as it celebrates 20 years in business. The partnership with CERES Pharma means an expanded product portfolio, while preserving the quality that has made our products famous,” said Calin Ianta and Radu Ionescu-Heroiu, Dacia Plant shareholders.
CERES Pharma, a company established by Mario Debel and Alychlo in 2017, is active in the development and distribution of medicines, medical devices, biocides, cosmetics and focuses in particular on natural products.
The growth strategy of the company focuses on expanding its product portfolio by developing qualitative dietary supplements and pharmaceutical preparations in the Benelux and Central and Eastern Europe in the coming years.
In 2021, CERES Pharma was acquired by the Nexicap Partners, one of France’s leading private equity firms.
UniCredit Bank Romania, through the Investment Banking and Advisory team supervised by Alexandra Popa as managing director, was the exclusive financial advisor to Dacia Plant shareholders in the sale process, and the Corporate M&A team of law firm Wolf Theiss, led by Ileana Glodeanu, partner, provided legal assistance in all stages of the transaction.
(English version by Loredana Fratila-Cristescu)